This information was published on 2026-04-19T00:07:01 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2604556 |
| (220) |
18 Nov 2025
|
| (511) (510) |
Class 5
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions |
| (540) | LYRZO |
| (550) | Word |
| (730) |
AbbVie Inc.
|
| (750) |
Ashurst Australia
|
Find out more about publications on the About page.